Agenix formalizes secondary distribution arrangements...

Agenix formalizes secondary distribution arrangements for
anti-HBV drug
Receives minimum order for 12 months of RMB28 million (A$4.1
million)
Sinopharm Medicine Holding Co., Ltd (“Sinopharm”), China’s largest pharmaceutical
distribution company, has entered into an agreement with Agenix Bio-Pharmaceutical
(Shanghai) to distribute YouHeDing, Agenix’s anti- hepatitis B virus (“anti-HBV”)
drug, in secondary regional areas in China.
Sinopharm has provided a letter of intent to acquire no less than 400,000 bottles of
YouHeDing with an order value of approximately RMB28 million (A$4.1 million)
within 12 months.